1. Home
  2. MURA vs BOSC Comparison

MURA vs BOSC Comparison

Compare MURA & BOSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MURA
  • BOSC
  • Stock Information
  • Founded
  • MURA 2013
  • BOSC 1990
  • Country
  • MURA Ireland
  • BOSC Israel
  • Employees
  • MURA N/A
  • BOSC N/A
  • Industry
  • MURA
  • BOSC Computer Communications Equipment
  • Sector
  • MURA
  • BOSC Telecommunications
  • Exchange
  • MURA Nasdaq
  • BOSC Nasdaq
  • Market Cap
  • MURA 35.7M
  • BOSC 29.6M
  • IPO Year
  • MURA N/A
  • BOSC 1996
  • Fundamental
  • Price
  • MURA $2.08
  • BOSC $4.89
  • Analyst Decision
  • MURA Strong Buy
  • BOSC
  • Analyst Count
  • MURA 3
  • BOSC 0
  • Target Price
  • MURA $12.00
  • BOSC N/A
  • AVG Volume (30 Days)
  • MURA 465.5K
  • BOSC 70.4K
  • Earning Date
  • MURA 11-12-2025
  • BOSC 08-21-2025
  • Dividend Yield
  • MURA N/A
  • BOSC N/A
  • EPS Growth
  • MURA N/A
  • BOSC 55.92
  • EPS
  • MURA N/A
  • BOSC 0.52
  • Revenue
  • MURA N/A
  • BOSC $46,768,000.00
  • Revenue This Year
  • MURA N/A
  • BOSC N/A
  • Revenue Next Year
  • MURA N/A
  • BOSC N/A
  • P/E Ratio
  • MURA N/A
  • BOSC $9.25
  • Revenue Growth
  • MURA N/A
  • BOSC 15.66
  • 52 Week Low
  • MURA $0.95
  • BOSC $2.50
  • 52 Week High
  • MURA $4.74
  • BOSC $5.50
  • Technical
  • Relative Strength Index (RSI)
  • MURA 52.70
  • BOSC 53.95
  • Support Level
  • MURA $2.05
  • BOSC $4.65
  • Resistance Level
  • MURA $2.09
  • BOSC $4.91
  • Average True Range (ATR)
  • MURA 0.01
  • BOSC 0.16
  • MACD
  • MURA 0.01
  • BOSC 0.01
  • Stochastic Oscillator
  • MURA 66.67
  • BOSC 41.43

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

About BOSC B.O.S. Better Online Solutions

BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.

Share on Social Networks: